Status:
UNKNOWN
The Efficacy and the Safety of Dexmedetomidine Sedation on the Pediatric Intensive Unit(PICU) Patients.
Lead Sponsor:
Anhui Provincial Children's Hospital
Conditions:
Failed Conscious Sedation During Procedure
Eligibility:
All Genders
1-16 years
Phase:
PHASE4
Brief Summary
To observe the efficacy and safety of dexmedetomidine sedation on the patients admitted to the pediatric intensive care unit after surgery.
Eligibility Criteria
Inclusion
- written informed consent；
- pediatric patients admitted to intensive care unit after general anesthesia;
- expected mechanical ventilation time \>6 hours; （4）1 months to 16 years old; -
Exclusion
- congenital heart disease, arrhythmias and heart failure;
- Alanine transaminase（ALT） and (or) Aspartate aminotransferase（AST） level is more than twice the upper limit of normal;
- Creatinine and (or) Blood urea nitrogen（BUN） is more than the upper limit of normal;
- central nervous system disease;
- spinal analgesia or muscle relaxants is used during PICU;
- the drug that affects the nerve conduction is used in one month;
- allergy to the test drug or having other contraindications;
- participated in other studies 30 days prior to admission of PICU; -
Key Trial Info
Start Date :
December 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2015
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT02296073
Start Date
December 1 2014
End Date
December 1 2015
Last Update
November 21 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.